HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by von Herrath, M. G. Articles by Hughes, A. Search for Related Content PubMed PubMed Citation Articles by von Herrath, M. G. Articles by Hughes, A. Social Bookmarking                What's this?

Protection From Type 1 Diabetes in the Face of High Levels of Activated Autoaggressive Lymphocytes in a Viral Transgenic Mouse Model Crossed to the SV129 Strain

Immunology and Neuropharmacology, the Scripps Research Institute, La Jolla, California

In comparing the incidence of virally induced type 1 diabetes in F₁ crosses of RIP-LCMV mice to three different mouse strains identical at the major histocompatibility complex H-2D^b locus, we surprisingly found that disease development was reduced by 80% in F₁ crosses to the SV129 genetic background and by 60% after eight backcrosses to the original C57BL/6 RIP-LCMV mice. In this model, diabetes is strongly dependent on a virally induced H-2D^b–restricted cytotoxic T-cell (CTL) response. Importantly, numbers and effector functions of autoaggressive CD4 and CD8 lymphocytes were not decreased in the protected mice, and CTLs were still able to kill syngeneic islet cells in vitro with equal efficacy compared with CTLs from the original RIP-LCMV strain. Furthermore, CTLs were able to extravasate into islets in vivo, and no evidence for induction of regulatory cells was observed. However, regeneration of ß-cells in islets under "attack" occurred only in the protected SV129-crossed animals, whereas it was not evident at any time in any mice that developed diabetes. Thus, genetic factors can "override" the diabetogenic potential of high numbers of autoaggressive lymphocytes through, for example, increased islet regeneration. This finding has important implications for interpreting numbers and pathogenicity of autoreactive lymphocytes in prediabetic patients of genetically diverse backgrounds.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				D. Yin, J. Tao, D. D. Lee, J. Shen, M. Hara, J. Lopez, A. Kuznetsov, L. H. Philipson, and A. S. Chong Recovery of Islet {beta}-Cell Function in Streptozotocin- Induced Diabetic Mice: An Indirect Role for the Spleen Diabetes, December 1, 2006; 55(12): 3256 - 3263. [Abstract] [Full Text] [PDF]

				A. E. Juedes, E. Rodrigo, L. Togher, L. H. Glimcher, and M. G. von Herrath T-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes J. Exp. Med., April 19, 2004; 199(8): 1153 - 1162. [Abstract] [Full Text] [PDF]